Apr 29, 2026 | Uncategorized
J Subst Use Addict Treat. 2026 Apr 28:209986. doi: 10.1016/j.josat.2026.209986. Online ahead of print.ABSTRACTINTRODUCTION: Higher buprenorphine maintenance doses (>24 mg daily) may be more effective in improving opioid use disorder (OUD) treatment outcomes in the...
Apr 25, 2026 | Uncategorized
J Subst Use Addict Treat. 2026 Apr 24:209998. doi: 10.1016/j.josat.2026.209998. Online ahead of print.ABSTRACTDespite comprising one-fifth of the population, individuals living in rural areas are underrepresented in clinical trials on substance use disorders (SUD)....
Apr 19, 2026 | Uncategorized
JAMA Intern Med. 2026 Apr 20. doi: 10.1001/jamainternmed.2026.0428. Online ahead of print.NO ABSTRACTPMID:42008248 | DOI:10.1001/jamainternmed.2026.0428
Mar 25, 2026 | Uncategorized
J Pain. 2026 Mar 24:106269. doi: 10.1016/j.jpain.2026.106269. Online ahead of print.ABSTRACTChronic pain is common and burdensome among people with end stage kidney disease (ESKD). Pain management options are limited and prescription opioids are often used in this...
Mar 16, 2026 | Uncategorized
Subst Use Addctn J. 2026 Mar 17:29767342261421746. doi: 10.1177/29767342261421746. Online ahead of print.ABSTRACTBACKGROUND: Harm reduction services fulfill a critical need in reducing the negative consequences associated with the overdose crisis. However, many...
Mar 15, 2026 | Uncategorized
JAMA Netw Open. 2026 Mar 2;9(3):e260667. doi: 10.1001/jamanetworkopen.2026.0667.NO ABSTRACTPMID:41838008 | DOI:10.1001/jamanetworkopen.2026.0667
